Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Cole

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|February 1, 2025
Emotional past and future events after pulvinar damage: A neuropsychological case seriesScott Cole, Karl Szpunar, Roland Benoit, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 4, 2006
Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometryThomas F Kalhorn, William N Howald, Scott Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortalityJeannine S McCune, Ami Batchelder, H Joachim Deeg, et al.
Clinical Pharmacology and Therapeutics|September 13, 2005
Metabolism-based cyclophosphamide dosing for hematopoietic cell transplantGeorge B McDonald, Jeannine S McCune, Ami Batchelder, et al.
Journal of Environmental Management|September 3, 2021
Metrics for environmental compensation: A comparative analysis of Swedish municipalitiesTore Söderqvist, Scott Cole, Frida Franzén, et al.
Blood|September 8, 2005
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantationLuisa Giaccone, Jeannine S McCune, Michael B Maris, et al.
Lancet (London, England)|February 16, 2021
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trialSumanta K Pal, Catherine Tangen, Ian M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell CarcinomaPedro Barata, Catherine Tangen, Melissa Plets, et al.
Memory & Cognition|July 11, 2022
Collective remembering and future forecasting during the COVID-19 pandemic: How the impact of COVID-19 affected the themes and phenomenology of global and national memories across 15 countriesSezin Öner, Lynn Ann Watson, Zeynep Adıgüzel, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|February 1, 2025
Emotional past and future events after pulvinar damage: A neuropsychological case seriesScott Cole, Karl Szpunar, Roland Benoit, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 4, 2006
Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometryThomas F Kalhorn, William N Howald, Scott Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortalityJeannine S McCune, Ami Batchelder, H Joachim Deeg, et al.
Clinical Pharmacology and Therapeutics|September 13, 2005
Metabolism-based cyclophosphamide dosing for hematopoietic cell transplantGeorge B McDonald, Jeannine S McCune, Ami Batchelder, et al.
Journal of Environmental Management|September 3, 2021
Metrics for environmental compensation: A comparative analysis of Swedish municipalitiesTore Söderqvist, Scott Cole, Frida Franzén, et al.
Blood|September 8, 2005
Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantationLuisa Giaccone, Jeannine S McCune, Michael B Maris, et al.
Lancet (London, England)|February 16, 2021
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trialSumanta K Pal, Catherine Tangen, Ian M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell CarcinomaPedro Barata, Catherine Tangen, Melissa Plets, et al.
Memory & Cognition|July 11, 2022
Collective remembering and future forecasting during the COVID-19 pandemic: How the impact of COVID-19 affected the themes and phenomenology of global and national memories across 15 countriesSezin Öner, Lynn Ann Watson, Zeynep Adıgüzel, et al.
Pageof 2